AMGN Sentiment Analysis

Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve

Published on July 30, 2025

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....

Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025

Published on April 22, 2025

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy

Published on March 20, 2025

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market

Published on March 19, 2025

Amgen Inc....

Amgen Inc. Continues to Impress Hedge Funds with Strong Performance

Published on March 17, 2025

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy

Published on March 16, 2025

Amgen Inc....

AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave

Published on March 10, 2025

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20....

AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave

Published on March 7, 2025

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19....

Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry

Published on February 27, 2025

Amgen Inc....

Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Published on February 26, 2025

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....

Amgen Inc. AMGN Reports Strong Earnings Amidst Growing Bull Case Theory

Published on February 20, 2025

Amgen Inc. (AMGN), a leading biotechnology company, has recently reported strong earnings, surpassing market expectations....

Amgen Inc. AMGN: Absurd That This Stock Sells for 14x Earnings

Published on February 14, 2025

Amgen Inc....

Amgen Inc AMGN Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions

Published on February 10, 2025

Amgen Inc (AMGN) recently held its Q4 2024 earnings call, where it highlighted robust revenue growth and strategic expansions....

Amgen Inc. AMGN Continues to Impress Hedge Funds and Experts

Published on February 7, 2025

Amgen Inc....

Amgen Inc. Reports Strong Q4 Earnings with Revenue Surpassing Estimates

Published on February 6, 2025

Amgen Inc., a leading biotechnology company, has reported impressive fourth-quarter earnings....

Is Amgen Inc. AMGN the Best Cancer Stock to Buy According to Hedge Funds

Published on February 5, 2025

Amgen Inc. (NASDAQ: AMGN) has caught the attention of hedge funds as a potential investment in the cancer sector....

Amgen Inc. AMGN Reports Next Week: Wall Street Expects Earnings Growth

Published on February 4, 2025

Amgen Inc....

Amgen Inc. Continues to Impress with Strong Quarterly Earnings

Published on February 3, 2025

Amgen Inc....

Amgen Inc. AMGN - Investing in a Cheap Quarterly Dividend Stock

Published on February 2, 2025

Amgen Inc., a leading biotechnology company, presents an exciting investment opportunity for shareholders....

Amgen Inc. Continues to Attract Attention with Unexpected Stock Movements

Published on January 29, 2025

Amgen Inc., a leading biotechnology company, has been generating significant interest among investors lately....

Amgen Inc. (AMGN) Shows Promise as a High-Yielding Dividend Stock

Published on January 25, 2025

Amgen Inc....

Amgen Inc. AMGN: A Strong Contender for Long-term Investment

Published on January 24, 2025

Amgen Inc. (NASDAQ: AMGN) is emerging as a top choice among investors looking for long-term growth....

Amgen Inc. (AMGN) Shows Promising Dividend Yield, Making it a Top Choice for Investors

Published on January 22, 2025

Amgen Inc....

Amgen Inc. Continues to be a Top Value Stock for the Long-Term

Published on January 14, 2025

Amgen Inc. (NASDAQ:AMGN) has consistently proven itself as a top value stock for long-term investors....

Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership

Published on January 11, 2025

Amgen Inc....